Patents by Inventor Amber Clausi

Amber Clausi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
    Patent number: 8808710
    Abstract: The disclosure provides a method of preparing an immunologically-active adjuvant-bound freeze dried vaccine composition. A specific embodiment provides a stable vaccine composition comprising an aluminum-salt adjuvant, a recombinant Clostridium botulinum neurotoxin protein and a glass-forming agent. These vaccine compositions are useful in the treatment of humans and other animals at risk of infection from Clostridium botulinum neurotoxin.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: August 19, 2014
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Theodore Randolph, Amber Clausi, John F Carpenter, Daniel K. Schwartz
  • Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition
    Publication number: 20130315966
    Abstract: The disclosure provides a method of preparing an immunologically-active adjuvant-bound freeze dried vaccine composition. A specific embodiment provides a stable vaccine composition comprising an aluminum-salt adjuvant, a recombinant Clostridium botulinum neurotoxin protein and a glass-forming agent. These vaccine compositions are useful in the treatment of humans and other animals at risk of infection from Clostridium botulinum neurotoxin.
    Type: Application
    Filed: May 20, 2013
    Publication date: November 28, 2013
    Applicant: The Regents of the University of Colorado
    Inventors: Theodore Randolph, Amber Clausi, John F. Carpenter, Daniel K. Schwartz
  • Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
    Patent number: 8444991
    Abstract: The disclosure provides a method of preparing an immunologically-active adjuvant-bound freeze dried vaccine composition. A specific embodiment provides a stable vaccine composition comprising an aluminum-salt adjuvant, a recombinant Clostridium botulinum neurotoxin protein and a glass-forming agent. These vaccine compositions are useful in the treatment of humans and other animals at risk of infection from Clostridium botulinum neurotoxin.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: May 21, 2013
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Theodore W. Randolph, Amber Clausi, John F. Carpenter, Daniel K. Schwartz
  • Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition
    Publication number: 20100158951
    Abstract: The disclosure provides a method of preparing an immunologically-active adjuvant-bound freeze dried vaccine composition. A specific embodiment provides a stable vaccine composition comprising an aluminum-salt adjuvant, a recombinant Clostridium botulinum neurotoxin protein and a glass-forming agent. These vaccine compositions are useful in the treatment of humans and other animals at risk of infection from Clostridium botulinum neurotoxin.
    Type: Application
    Filed: March 18, 2008
    Publication date: June 24, 2010
    Inventors: Theodore W. Randolph, Amber Clausi, John F. Carpenter, Daniel K. Schwartz